Salicylate toxicity is a complex, potentially life-threatening poisoning that may occur from acute ingestion (intentional overdose) or chronic therapeutic overuse. There is no specific antidote; management centers on aggressive volume resuscitation, urinary alkalinization with IV sodium bicarbonate, GI decontamination, and hemodialysis for severe cases. [1-2]
1. History
- Type of exposure: Acute (single large ingestion, often intentional) vs. chronic (therapeutic overuse, often elderly)
- Substance ingested: Aspirin, bismuth subsalicylate (Pepto-Bismol), oil of wintergreen (methyl salicylate — extremely concentrated and dangerous), topical salicylate preparations, willow bark supplements [2-3]
- Amount and timing: Estimate total dose ingested and time since ingestion; enteric-coated or sustained-release formulations delay peak levels [1]
- Coingestions: Ethanol, opioids, or CNS depressants slow gastric emptying and blunt the compensatory hyperventilation, worsening toxicity [1-2]
- Symptom progression: Early — tinnitus, nausea, vomiting, hyperpnea; Late — confusion, agitation, diaphoresis, fever, seizures [1]
- Chronic use history: Daily aspirin dose, recent dose increases, renal function, dehydration triggers
2. Alarm Features
- Altered mental status (agitation, delirium, obtundation) — indicates CNS salicylate penetration and is an indication for hemodialysis regardless of level [4]
- Acidemia (pH <7.35) — seen in severe poisoning; worsens CNS drug distribution and predicts poor outcome [2]
- Respiratory fatigue — loss of compensatory hyperventilation is a pre-arrest sign
- Seizures, coma, cerebral edema
- Noncardiogenic pulmonary edema / ARDS requiring supplemental oxygen [1][4]
- Hyperthermia — indicates severe uncoupling of oxidative phosphorylation [1]
- Cardiovascular collapse — at levels >75 mg/dL [1]
- Rising salicylate levels despite treatment — suggests bezoar or ongoing absorption [1]
- Clinical deterioration with falling serum levels — ominous sign of tissue redistribution [2]
3. Medications
Relevant contributors
- Aspirin (all formulations, especially enteric-coated)
- Bismuth subsalicylate, methyl salicylate (oil of wintergreen), topical salicylate creams [2]
- Combination products: butalbital/aspirin/caffeine [5]
Key treatments
- IV sodium bicarbonate (cornerstone of therapy) [1-2]
- Activated charcoal (GI decontamination) [1][6]
- IV dextrose (for CNS hypoglycorrhachia, even with normal serum glucose) [1-2]
- Potassium chloride supplementation (hypokalemia impairs urinary alkalinization) [1-2]
Contraindicated / Caution
- Acetazolamide — contraindicated; induces systemic acidemia and increases free salicylate levels [1]
- Oral bicarbonate — contraindicated; raises GI pH and accelerates dissolution of remaining tablets [1]
- CNS/respiratory depressants (opioids, benzodiazepines) — suppress compensatory hyperventilation and can precipitate clinical deterioration [2]
4. Diet
- NPO in the acute setting due to vomiting risk and potential need for intubation or hemodialysis
- Glucose supplementation is critical — CNS glucose utilization is increased, and hypoglycorrhachia can occur even with normal serum glucose [1-2]
- Chronic salicylate users: counsel on avoiding excessive aspirin intake, especially with dehydration or fasting
5. Review of Systems
- Neuro: Tinnitus, hearing loss, vertigo, confusion, agitation, hallucinations, seizures, lethargy
- Respiratory: Dyspnea, tachypnea/hyperpnea (early and prominent)
- GI: Nausea, vomiting, abdominal pain, hematemesis
- Constitutional: Fever, diaphoresis, malaise
- Renal: Decreased urine output
- Musculoskeletal: Muscle rigidity (rare but can cause rhabdomyolysis) [1]
6. Collateral History and Family History
- Collateral: Pill bottles, empty containers, pharmacy records, suicide note, witness accounts of ingestion timing and amount
- Psychiatric history: Prior overdose attempts, depression, suicidal ideation — acute ingestion is often intentional in young adults [1]
- Medication access: Other household members' medications, OTC products
- Family history: Not directly relevant to toxicity, but psychiatric family history may inform risk assessment
7. Risk Factors
- Acute toxicity: Psychiatric illness, prior overdose attempts, access to large quantities of aspirin [1]
- Chronic toxicity: Elderly patients on therapeutic aspirin, renal insufficiency, dehydration, concurrent illness (fever, infection), cognitive impairment leading to dosing errors [1]
- High-risk formulations: Enteric-coated tablets (delayed absorption), oil of wintergreen/methyl salicylate (1 mL = 1.4 g salicylate — extremely toxic in small volumes) [3]
- Coingestion of CNS depressants blunts hyperventilation and masks early signs [1-2]
8. Differential Diagnosis
- Sepsis — chronic salicylate toxicity can mimic sepsis with hypotension, tachypnea, fever, altered mental status, and lactic acidosis [1]
- Diabetic ketoacidosis — elevated anion gap metabolic acidosis with Kussmaul respirations
- Toxic alcohol ingestion (methanol, ethylene glycol) — elevated anion gap, altered mental status
- Theophylline toxicity — tachycardia, vomiting, seizures, metabolic acidosis
- Iron poisoning — GI symptoms, metabolic acidosis
- CNS infection (meningitis/encephalitis) — fever, altered mental status, tachypnea
- Reye syndrome (pediatric) — hepatic failure, encephalopathy after aspirin use
Key distinguishing feature: The combination of primary respiratory alkalosis with superimposed elevated anion gap metabolic acidosis is highly characteristic of salicylate toxicity in adults. [1][7]
9. Past Medical History
- Chronic aspirin or NSAID use
- Renal insufficiency (lowers threshold for toxicity and hemodialysis) [4]
- Hepatic disease (impairs salicylate metabolism)
- CHF or pulmonary disease (limits fluid resuscitation)
- Prior overdose episodes
- Psychiatric diagnoses
10. Physical Exam
Vital signs
- Tachypnea/hyperpnea — the hallmark finding; deep, rapid respirations from direct medullary stimulation [1]
- Tachycardia
- Hyperthermia (can be >40°C in severe cases)
- Hypotension (late, from volume depletion)
Focused exam
- Neuro: Level of consciousness, agitation, asterixis, paratonia/rigidity, seizure activity
- Lungs: Crackles (noncardiogenic pulmonary edema)
- Abdomen: Epigastric tenderness, signs of GI hemorrhage
- Skin: Diaphoresis, flushing
- Mucous membranes: Dry (dehydration)
11. Lab Studies
- Serum salicylate level — obtain immediately and repeat every 2 hours until clearly declining [2]
- Therapeutic: 15–30 mg/dL
- Toxic: >40–50 mg/dL
- Severe: >70 mg/dL
- Hemodialysis threshold: >90 mg/dL (or >80 mg/dL with renal impairment) [1][4]
- ABG — essential; expect mixed respiratory alkalosis + elevated anion gap metabolic acidosis [1]
- BMP — anion gap (beware: salicylate can cause pseudohyperchloremia on ion-selective electrode analyzers, masking the elevated anion gap) [8-9]
- Serum potassium — hypokalemia is common and must be corrected to achieve urinary alkalinization [2]
- Serum glucose — may be high early, low late; CNS hypoglycorrhachia can occur with normal serum glucose [1]
- Lactate — often elevated
- Coagulation studies (PT/INR) — salicylate impairs platelet function and can cause hypoprothrombinemia
- Hepatic panel, lipase
- Urine pH — target >7.5 during alkalinization [2]
- Urine drug screen and acetaminophen level — always check for coingestion
12. Imaging
- Chest X-ray: Evaluate for noncardiogenic pulmonary edema/ARDS
- CT head: If altered mental status to evaluate for cerebral edema or alternative diagnoses
- Abdominal X-ray/KUB: May show pill concretions/bezoar (aspirin tablets can be radiopaque)
- Imaging is otherwise not routinely required for diagnosis
13. Special Tests
- Done nomogram — historically used but not reliable for predicting severity in either acute or chronic toxicity; should not guide management decisions [2]
- Serial salicylate levels every 1–2 hours until peak confirmed and declining [10]
- Serial ABGs — monitor acid-base status closely; a falling pH with clinical deterioration is ominous even if salicylate levels are declining [2]
- Urine pH — check frequently to confirm alkalinization goal >7.5 [2]
- Point-of-care glucose — frequent monitoring given risk of hypoglycemia
14. ECG
- Sinus tachycardia — most common finding
- QT prolongation — can occur with severe electrolyte disturbances (hypokalemia, hypocalcemia from alkalinization)
- Dysrhythmias — rare but possible in severe toxicity with cardiovascular collapse
- ECG is indicated to evaluate for coingestion effects and electrolyte-related conduction abnormalities
15. Assessment
Severity stratification by acid-base status (per the American College of Medical Toxicology): [2]
- Mild: Respiratory alkalosis only (tinnitus, nausea, hyperpnea)
- Moderate: Normal or near-normal pH (7.35–7.45) with underlying respiratory alkalosis + metabolic acidosis
- Severe: Acidemia (pH <7.35), altered mental status, ARDS, cerebral edema, cardiovascular collapse
Critical pearls
- Chronic toxicity carries higher morbidity and mortality than acute toxicity due to delayed diagnosis [1]
- Clinical deterioration with falling serum levels suggests tissue redistribution — this is an ominous sign [2]
- The time of ingestion, plasma level, and clinical toxicity are only loosely correlated [1]
- Enteric-coated formulations can cause delayed and prolonged absorption [1]
The following figure illustrates the pH-dependent mechanisms of urinary alkalinization and hemodialysis for salicylate removal:
16. Treatment Plan
Initial stabilization
- ABCs with emphasis on maintaining hyperventilation — do not suppress the respiratory drive [1-2]
- IV access, continuous monitoring, Foley catheter for urine output and pH monitoring
Volume resuscitation
- LR or NS at 10–20 mL/kg/hr for first 2 hours, then adjust to maintain UOP 1–1.5 mL/kg/hr [1]
- Goal is euvolemia, not forced diuresis (risk of pulmonary edema) [1]
Urinary alkalinization (initiate in all symptomatic patients):
- IV NaHCO₃ bolus: 1–2 mEq/kg
- Continuous infusion: 3 ampules NaHCO₃ (132 mEq) in 1 L D5W + 40 mEq KCl; run at 1.5–2× maintenance [1-2]
- Target urine pH >7.5, serum pH <7.5 [1][6]
- Continue until salicylate level <40 mg/dL, metabolic acidosis resolved, and patient asymptomatic [1]
GI decontamination
- Activated charcoal: 1–2 g/kg (max 100 g adults); most effective within 2 hours but can be given later for large ingestions [1]
- Multi-dose activated charcoal: Repeat every 4 hours for bezoars, enteric-coated, or sustained-release formulations [1][6]
- Whole-bowel irrigation: Consider if levels continue to rise despite charcoal [1]
Glucose supplementation
- Dextrose 0.5–1 g/kg bolus[1-2]
Hemodialysis indications (per EXTRIP recommendations): [4]
- Salicylate level >100 mg/dL (strong recommendation) or >90 mg/dL regardless of symptoms
- Level >80 mg/dL with impaired renal function
- Altered mental status, ARDS requiring O₂, or standard therapy failing — regardless of level
- Severe acidemia (pH ≤7.20)
- Intermittent HD is preferred; CRRT is acceptable if hemodynamically unstable [4][11]
Intubation — extreme caution
- Only if respiratory efforts are truly failing or airway protection is needed [1-2]
- Pre-intubation NaHCO₃ bolus (2 mEq/kg) to prevent pH drop [1-2]
- Must maintain high minute ventilation post-intubation — match the patient's pre-intubation respiratory rate and tidal volume [2]
- Most experienced provider should intubate for best chance of first-pass success [1]
17. Disposition
ICU admission
- Salicylate level >50 mg/dL (acute ingestion)
- Any altered mental status, acidemia, or hemodynamic instability
- Need for hemodialysis or intubation
- Rising salicylate levels despite treatment
Monitored bed / observation
- Symptomatic patients with levels 40–50 mg/dL responding to alkalinization
- Enteric-coated ingestions (delayed peak — must observe with serial levels)
Discharge criteria
- Salicylate level <40 mg/dL and clearly declining on serial measurements
- Normal acid-base status
- Asymptomatic with normal respiratory rate and effort
- Adequate oral intake and normal mental status
- Psychiatric clearance if intentional ingestion [1]
Consult triggers
- Toxicology — early consultation recommended for all cases [1]
- Nephrology — notify early if any possibility of hemodialysis (preparation time can cause significant delays) [2]
- Psychiatry — for all intentional ingestions
18. Follow Up / Return Precautions
Follow-up timing
- PCP or toxicology follow-up within 24–48 hours if discharged
- Psychiatric follow-up if intentional ingestion
- Recheck BMP and renal function within 1 week if significant toxicity
Return precautions — instruct patients to return immediately for:
- Recurrence of tinnitus, nausea, vomiting
- Rapid or deep breathing
- Confusion, drowsiness, or agitation
- Fever
- Decreased urine output
Patient counseling
- Educate on safe aspirin dosing and dangers of exceeding recommended doses
- Counsel on keeping salicylate-containing products (especially oil of wintergreen) out of reach of children
- Expected recovery: most patients with timely treatment recover fully; chronic toxicity may have a more prolonged course [1]
References
1. Salicylate Toxicity. — Palmer BF, Clegg DJ. The New England Journal of Medicine. 2020.
2. Guidance Document: Management Priorities in Salicylate Toxicity. — Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology. 2015.
3. Severe Salicylate Poisoning Due to Teaberry Flavoring Ingestion: A Case Report. — Berggren J, Jones C, Katz KD. The Journal of Emergency Medicine. 2025.
4. Extracorporeal Treatment for Salicylate Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. — Juurlink DN, Gosselin S, Kielstein JT, et al. Annals of Emergency Medicine. 2015.
5. FDA Drug Label. — Updated date: 2024-12-02. Food and Drug Administration.
6. Acute Medication Poisoning. — Vega IL, Griswold MK, Laskey D. American Family Physician. 2024.
7. Protection of Acid–Base Balance by pH Regulation of Acid Production. — Hood VL, Tannen RL. The New England Journal of Medicine. 1998.
8. Pseudohyperchloremia and Negative Anion Gap - Think Salicylate!. — Wiederkehr MR, Benevides R, Santa Ana CA, Emmett M. The American Journal of Medicine. 2021.
9. Case Report: Salicylate Intoxication Can Present With a Normal Anion Gap Metabolic Acidosis Depending on Method Used for Measuring Chloride. — Buisman L, Riphagen IJ, Kwant M, et al. British Journal of Clinical Pharmacology. 2022.
10. FDA Drug Label. — Updated date: 2018-06-19. Food and Drug Administration.
11. We use Continuous Renal Replacement Therapy for Overdoses and Intoxications. — Cabrera VJ, Shirali AC. Seminars in Dialysis. 2016.